• Capio Biosciences

Capio Biosciences receives QNBV Certification from Wisconsin Economic Development Corporation (WEDC)

Capio Biosciences is pleased to announce that they have received Qualified New Business Venture (QNBV) certification from WEDC. The QNBV program provides tax credits to eligible Angel and Venture Fund investors who make cash equity investments in qualified early-stage businesses. If all eligibility requirements are met, investors receive a Wisconsin income tax credit equal to 25 percent of the value of the investment made in the certified company. The investments incented by this program provide the capital necessary for emerging growth companies to develop new products and technologies, move products to market and provide high-quality jobs in Wisconsin. If you are a Wisconsin-based investor and want to learn more about Capio Biosciences or the QNBV program please email your enquiry to info@capiobiosciences.com. Further information regarding WEDC and the QNBV program can be found at https://wedc.org/ under "Entrepreneur Programs".



Need more details? Contact us.

 

We are here to assist. If you require further information or are interested in collaborations or partnerships, contact us by phone, email or via our social media channels.

* The CapioCyte System is currently under development and not for use in diagnostic procedures.

© COPYRIGHT 2017, 2018. ALL RIGHTS RESERVED. 

Capio and CapioCyte are trademarks of Capio Biosciences.

  • White LinkedIn Icon
  • White Twitter Icon
  • White Facebook Icon

505 S. Rosa Road
Suite 20A
Madison, WI 53719

info@capiobiosciences.com

608-441-8375